Rubinstein-Taybi syndrome caused by a De Novo reciprocal translocation t(2;16)(q36.3;p13.3)
- PMID: 10797422
- DOI: 10.1002/(sici)1096-8628(20000501)92:1<47::aid-ajmg8>3.0.co;2-h
Rubinstein-Taybi syndrome caused by a De Novo reciprocal translocation t(2;16)(q36.3;p13.3)
Abstract
Rubinstein-Taybi syndrome (RTS) is a multiple congenital anomalies and mental retardation syndrome characterized by facial abnormalities, broad thumbs, and broad big toes. We have shown previously that disruption of the human CREB-binding protein (CBP) gene, either by gross chromosomal rearrangements or by point mutations, leads to RTS. Translocations and inversions involving chromosome band 16p13.3 form the minority of CBP mutations, whereas microdeletions occur more frequently (approximately 10%). Breakpoints of six translocations and inversions in RTS patients described thus far were found clustered in a 13-kb intronic region at the 5' end of the CBP gene and could theoretically only result in proteins containing the extreme N-terminal region of CBP. In contrast, in one patient with a translocation t(2;16)(q36.3;p13.3) we show by using fiber FISH and Southern blot analysis that the chromosome 16 breakpoint lies about 100 kb downstream of this breakpoint cluster. In this patient, Western blot analysis of extracts prepared from lymphoblasts showed both a normal and an abnormal shorter protein lacking the C-terminal domain, indicating expression of both the normal and the mutant allele. The results suggest that the loss of C-terminal domains of CBP is sufficient to cause RTS. Furthermore, these data indicate the potential utility of Western blot analysis as an inexpensive and fast approach for screening RTS mutations.
Copyright 2000 Wiley-Liss, Inc.
Similar articles
-
Diagnostic analysis of the Rubinstein-Taybi syndrome: five cosmids should be used for microdeletion detection and low number of protein truncating mutations.J Med Genet. 2000 Mar;37(3):168-76. doi: 10.1136/jmg.37.3.168. J Med Genet. 2000. PMID: 10699051 Free PMC article.
-
Cryptic microdeletion of the CREBBP gene from t(1;16) (p36.2;p13.3) as a novel genetic defect causing Rubinstein-Taybi syndrome.Ann Clin Lab Sci. 2013 Fall;43(4):450-6. Ann Clin Lab Sci. 2013. PMID: 24247805
-
Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP.Nature. 1995 Jul 27;376(6538):348-51. doi: 10.1038/376348a0. Nature. 1995. PMID: 7630403
-
Tentative assignment of a locus for Rubinstein-Taybi syndrome to 16p13.3 by a de novo reciprocal translocation, t(7;16)(q34;p13.3).Am J Med Genet. 1992 Sep 15;44(2):237-41. doi: 10.1002/ajmg.1320440223. Am J Med Genet. 1992. PMID: 1456298 Review.
-
[Rubinstein-Taybi syndrome].Ryoikibetsu Shokogun Shirizu. 2000;(30 Pt 5):241-3. Ryoikibetsu Shokogun Shirizu. 2000. PMID: 11057213 Review. Japanese. No abstract available.
Cited by
-
Further peer review failures.Clinics (Sao Paulo). 2011;66(10):1833. doi: 10.1590/s1807-59322011001000025. Clinics (Sao Paulo). 2011. PMID: 22012059 Free PMC article. No abstract available.
-
Transcriptional/epigenetic regulator CBP/p300 in tumorigenesis: structural and functional versatility in target recognition.Cell Mol Life Sci. 2013 Nov;70(21):3989-4008. doi: 10.1007/s00018-012-1254-4. Epub 2013 Jan 11. Cell Mol Life Sci. 2013. PMID: 23307074 Free PMC article. Review.
-
Spectrum of CREBBP mutations in Indian patients with Rubinstein-Taybi syndrome.J Biosci. 2010 Jun;35(2):187-202. doi: 10.1007/s12038-010-0023-5. J Biosci. 2010. PMID: 20689175
-
Balanced translocations in mental retardation.Hum Genet. 2009 Jul;126(1):133-47. doi: 10.1007/s00439-009-0661-6. Epub 2009 Apr 5. Hum Genet. 2009. PMID: 19347365 Review.
-
First case report of inherited Rubinstein-Taybi syndrome associated with a novel EP300 variant.BMC Med Genet. 2016 Dec 13;17(1):97. doi: 10.1186/s12881-016-0361-8. BMC Med Genet. 2016. PMID: 27964710 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources